Limb anomalies in patients with CHARGE syndrome: An expansion of the phenotype

Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
American Journal of Medical Genetics Part A (Impact Factor: 2.16). 11/2007; 143A(22):2712-5. DOI: 10.1002/ajmg.a.32008
Source: PubMed


CHARGE syndrome is characterized by a wide clinical variability. During the past years the phenotypic spectrum was markedly expanded. Limb anomalies were initially not recognized as part of the phenotype but more recently mild limb anomalies were described in approximately 30% of the patients. We report on three patients with several major features of CHARGE syndrome who, in addition, presented severe limb anomalies including monodactyly, tibia aplasia, and bifid femora. Three different heterozygous truncating mutations in the CHD7 gene were detected. It has been hypothesized before that the CHARGE syndrome is caused by a disruption of mesenchymal-epithelial interaction. Given the expression of the CHD7 gene in the developing limb bud, it was anticipated that limb defects would belong to the spectrum of manifestations of CHARGE syndrome. The present observations provide further support to this hypothesis.

Download full-text


Available from: Dennis Dooijes,
  • Source
    • "g Vuorela et al., 2008. h Van de Laar et al., 2007. i Jongmans et al., 2006. "
    [Show abstract] [Hide abstract]
    ABSTRACT: CHARGE (coloboma, heart defects, atresia of choanae, retardation of growth and development, genital hypoplasia, and ear abnormalities) and 22q11.2 deletion syndromes are variable, congenital malformation syndromes that show considerable phenotypic overlap. We further explored this clinical overlap and proposed recommendations for the genetic diagnosis of both syndromes. We described 2 patients clinically diagnosed with CHARGE syndrome, who were found to carry a 22q11.2 deletion, and searched the literature for more cases. In addition, we screened our cohort of CHD7 mutation carriers (n = 802) for typical 22q11.2 deletion features and studied CHD7 in 20 patients with phenotypically 22q11.2 deletion syndrome but without haploinsufficiency of TBX1. In total, we identified 5 patients with a clinical diagnosis of CHARGE syndrome and a proven 22q11.2 deletion. Typical 22q11.2 deletion features were found in 30 patients (30/802, 3.7%) of our CHD7 mutation-positive cohort. We found truncating CHD7 mutations in 5/20 patients with phenotypically 22q11.2 deletion syndrome. Differentiating between CHARGE and 22q11.2 deletion syndromes can be challenging. CHD7 and TBX1 probably share a molecular pathway or have common target genes in affected organs. We strongly recommend performing CHD7 analysis in patients with a 22q11.2 deletion phenotype without TBX1 haploinsufficiency and conversely, performing a genome-wide array in CHARGE syndrome patients without a CHD7 mutation.
    Molecular syndromology 06/2013; 4(5):235-45. DOI:10.1159/000351127
  • Source
    • "It is notable that "club-foot", or congenital talipes equinovarus, is typically not due to osseous malformation. In 2007, Van de Laar et al reported 3 patients with heterozygous CHD7 truncating mutations in distinct exons, who displayed several limb malformations, including tibial aplasia, monodactyly and bifid femora [30]. Other limb defects, including triphalangeal thumb, polydactyly of the foot, ectrodactyly, and radial aplasia, have been reported as well [1,19,29,31]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: ABSTRACT: CHARGE is a phenotypically heterogeneous autosomal dominant disorder recognized as a cohesive syndrome since the identification of CHD7 as a genetic etiology. Classic features include: Coloboma, Heart defects, Atresia choanae, Retarded growth and development, Genitourinary abnormalities, and Ear anomalies and/or deafness. With greater accessibility to genetic analysis, a wider spectrum of features are emerging, and overlap with disorders such as DiGeorge syndrome, Kallmann syndrome, and Hypoparathyroidism Sensorineural Deafness and Renal Disease syndrome, is increasingly evident. We present a patient with a unique manifestation of CHARGE syndrome, including primary hypoparathyroidism and a limb anomaly; to our knowledge, he is also the first CHARGE subject reported with bilateral multicystic dysplastic kidneys. Furthermore, with structural modeling and murine expression studies, we characterize a putative CHD7 G744S missense mutation. Our report continues to expand the CHARGE phenotype and highlights that stringent fulfillment of conventional criteria should not strictly guide genetic analysis.
    International Journal of Pediatric Endocrinology 10/2011; 2011(1):11. DOI:10.1186/1687-9856-2011-11
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this paper we focus our attention on the new controller where the system is driven to the new equilibrium point as the adaptation runs, and try to assure better than just asymptotical stability. A real-time implementation of an adaptive nonlinear controller is investigated. The experimental setup of this power system includes a DC motor and synchronous machine connected to a large power system through a transmission line. Note that, major objectives in power system control design are to prevent an electric power system losing synchronism after a large sudden fault and to achieve a good post-fault regulation of the generator terminal voltage. In fact, the feedback control proposed here is assumed to achieve transient stabilization and voltage regulation when large and sudden faults occur to the transmission line, or to the DC motor, so that the mechanical power may permanently take any value within its physical bounds. The efficiency of the proposed controller has been verified via experimental results and compared to the performance of the standard linear controllers such as the automatic voltage regulator (AVR) and power stabilizer (PSS). Results of the experimental studies demonstrate the effectiveness of this nonlinear adaptive controller.
    Control, Communications and Signal Processing, 2004. First International Symposium on; 02/2004
Show more